VIDEO: Duravyu for wet AMD to enter phase 3 pivotal trials in second half of 2024
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Jay S. Duker, MD, of EyePoint Pharmaceuticals discusses lead product Duravyu.
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Jay S. Duker, MD, of EyePoint Pharmaceuticals discusses lead product Duravyu.
2233 S Martin Luther King Dr Chicago, IL 60616 Join Healio | HemOnc Today as we celebrate the risk-takers and groundbreakers at this prestigious awards…
Investigators undertook a secondary analysis of the effects of long-term, low-dose aspirin in over 3,000 older adults who satisfied the inclusion criteria in the Aspirin…
Patients with obesity have increased risk for CVD in part due to an atherogenic lipid profile, so reduction of weight, LDL and non-HDL should be…
The AIOLIS will be used to clinically evaluate patients’ perception of visual disturbances following premium IOL cataract surgery.
CHICAGO — High-deductible health plans appeared associated with shorter survival among cancer survivors, according to results of a nationwide population-based analysis presented at ASCO Annual…
SAN DIEGO — With dupilumab vs. placebo, adults with moderate to severe COPD and type 2 inflammation experienced fewer exacerbations, according to research presented at…
Consuming more flavonoids and flavonoid-rich foods such as tea, berries and apples was associated with a lower risk for type 2 diabetes, researchers found.According to…
Statins were associated with a reduced risk for CVD and death in older adults, even those aged 85 years and older, data in Annals of…
Use of remdesivir in hospitalized patients with COVID-19 and reduced eGFR did not decrease the risk of major adverse cardiovascular events or major adverse kidney…